{
  "docId": "019de071-b6aa-745b-9366-85da01204b7f",
  "docSlug": "36e600bcc4f8cdbd41dc817cb6eec90e",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 91 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 23,
  "pageCount": 91,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Includes a map-based visualization of regional product performance and a donut chart for revenue breakdown.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-b6aa-745b-9366-85da01204b7f/23",
  "deckHref": "/decks/019de071-b6aa-745b-9366-85da01204b7f",
  "deckJsonHref": "/decks/019de071-b6aa-745b-9366-85da01204b7f.json",
  "deckAnchorHref": "/decks/019de071-b6aa-745b-9366-85da01204b7f#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.78,
        "x": 0.11,
        "y": 0.135
      },
      "kind": "callout",
      "text": "International Rx: Saw 1% organic revenue decline vs. 3Q20, due to strong initial rebound in 3Q20 due to COVID-19",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bae8be12-68ff-4859-9503-f24506b7d24e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Revenue Breakdown by Region",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c8f1a9c-840d-47f1-b448-d3b06415de1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.74,
        "x": 0.25,
        "y": 0.92
      },
      "kind": "disclaimer",
      "text": "1. See Slide 2 and Appendix for further non-GAAP information. 2. Organic growth/change... 3. See footnote 3 at slide 6... 4. As of 9/30/2021.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "605a5592-5589-41ae-9e50-c5e56eb0ce8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.65,
        "x": 0.3,
        "y": 0.25
      },
      "kind": "image",
      "text": "World map background",
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b6135f5-0be1-4db5-97f8-326ccd24ffa8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.18,
        "x": 0.56,
        "y": 0.62
      },
      "kind": "list",
      "text": "Latin America Top 3 Products: Bedoyecta, Espaven, Dextrevit",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75a50be6-a321-450c-8e8b-5556d551d77b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.74,
        "y": 0.41
      },
      "kind": "list",
      "text": "EMEA, Russia, CIS Top 3 Products: Bisocard, Diclofenac, Sinupret",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5dde51b-d5d5-4822-9b6d-ecfcbcce1b73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.5,
        "y": 0.34
      },
      "kind": "list",
      "text": "Canada Top 3 Products: Jublia, Tiazac, Glumetza",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f44c76e2-8eba-4a88-8fb9-d291dcbcbc72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.03,
        "y": 0.31
      },
      "kind": "metric",
      "text": "YTD Organic Revenue: +6%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ac291ea-266a-4977-97c1-d4d1f43bc817",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.03,
        "y": 0.41
      },
      "kind": "metric",
      "text": "3Q21 Organic Revenue: (1%)",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4f09f4c-8e05-4625-9eba-80ee70954f45",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "International Rx³ 3Q21 Highlights – Recovery in Progress",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79135416-6cdd-40b1-9386-5f684a09d3d8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "aff41c7d-9e6c-48dc-a97d-efa7c1fed862",
      "evidence": "The slide mentions 'International Rx³ 3Q21 Highlights – Recovery in Progress', indicating a focus on a specific audience, likely investors or analysts.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 16,
      "beatId": "3301686e-d32a-433b-8780-603c1ac68052",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document presents growth initiatives and strategic alternatives",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 28,
      "from": 16,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "21cf5b4a-ca72-4285-ac92-38cb6528cb3d",
      "evidence": "The document highlights late-stage programs and recovery in progress",
      "position": 1,
      "objective": "Presenting growth initiatives",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}